Profil bibliographique

Jessica Bergonio

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

14Publications signalées

9Citations signalées

1Affiliations récentes

Les institutions déclarées

Les domaines associés

PARP inhibition in cancer therapyGenetics and Neurodevelopmental DisordersProtein Degradation and InhibitorsSarcoma Diagnosis and TreatmentRNA Research and Splicing

Les publications récentes

Accès ouvert 2025 article OpenAlex

Genetic and epigenetic characterization of sarcoma stem cells across subtypes identifies EZH2 as a therapeutic target

Edmond F. O’Donnell, Maria Muñoz, Ryan R. Davis, Jessica Bergonio et autres

us (code pays fourni par la source)

6 citations npj Precision Oncology

Accès ouvert 2024 supplementary-materials OpenAlex

Supplementary Tables S1A-S1K from Genetic Screen in a Preclinical Model of Sarcoma Development Defines Drivers and Therapeutic Vulnerabilities

Jack Freeland, Maria Muñoz, Edmond F. O’Donnell, Justin Langerman et autres

0 citations

Accès ouvert 2024 supplementary-materials OpenAlex

Supplementary Figure S4 from Genetic Screen in a Preclinical Model of Sarcoma Development Defines Drivers and Therapeutic Vulnerabilities

Jack Freeland, Maria Muñoz, Edmond F. O’Donnell, Justin Langerman et autres

0 citations

Accès ouvert 2024 supplementary-materials OpenAlex

Supplementary Figure S5 from Genetic Screen in a Preclinical Model of Sarcoma Development Defines Drivers and Therapeutic Vulnerabilities

Jack Freeland, Maria Muñoz, Edmond F. O’Donnell, Justin Langerman et autres

0 citations

Accès ouvert 2024 supplementary-materials OpenAlex

Supplementary Figure S7 from Genetic Screen in a Preclinical Model of Sarcoma Development Defines Drivers and Therapeutic Vulnerabilities

Jack Freeland, Maria Muñoz, Edmond F. O’Donnell, Justin Langerman et autres

0 citations

Accès ouvert 2024 supplementary-materials OpenAlex

Supplementary Figure S3 from Genetic Screen in a Preclinical Model of Sarcoma Development Defines Drivers and Therapeutic Vulnerabilities

Jack Freeland, Maria Muñoz, Edmond F. O’Donnell, Justin Langerman et autres

0 citations

Accès ouvert 2024 supplementary-materials OpenAlex

Supplementary Figure S9 from Genetic Screen in a Preclinical Model of Sarcoma Development Defines Drivers and Therapeutic Vulnerabilities

Jack Freeland, Maria Muñoz, Edmond F. O’Donnell, Justin Langerman et autres

0 citations

Accès ouvert 2024 supplementary-materials OpenAlex

Supplementary Figure S8 from Genetic Screen in a Preclinical Model of Sarcoma Development Defines Drivers and Therapeutic Vulnerabilities

Jack Freeland, Maria Muñoz, Edmond F. O’Donnell, Justin Langerman et autres

0 citations

Accès ouvert 2024 supplementary-materials OpenAlex

Supplementary Figure S2 from Genetic Screen in a Preclinical Model of Sarcoma Development Defines Drivers and Therapeutic Vulnerabilities

Jack Freeland, Maria Muñoz, Edmond F. O’Donnell, Justin Langerman et autres

0 citations

Accès ouvert 2024 supplementary-materials OpenAlex

Supplementary Figure S6 from Genetic Screen in a Preclinical Model of Sarcoma Development Defines Drivers and Therapeutic Vulnerabilities

Jack Freeland, Maria Muñoz, Edmond F. O’Donnell, Justin Langerman et autres

0 citations

Accès ouvert 2024 other OpenAlex

Data from Genetic Screen in a Preclinical Model of Sarcoma Development Defines Drivers and Therapeutic Vulnerabilities

Jack Freeland, Maria Muñoz, Edmond F. O’Donnell, Justin Langerman et autres

0 citations

Accès ouvert 2024 supplementary-materials OpenAlex

Supplementary Figure S1 from Genetic Screen in a Preclinical Model of Sarcoma Development Defines Drivers and Therapeutic Vulnerabilities

Jack Freeland, Maria Muñoz, Edmond F. O’Donnell, Justin Langerman et autres

0 citations

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.